Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 3Genitourinary 2Gastrointestinal 2Breast 2Thoracic 1Sarcoma 1Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 16Lung Neoplasms 5Carcinoma, Transitional Cell 4Carcinoma, Renal Cell 4Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 3Prostatic Neoplasms 3Ovarian Neoplasms 3Carcinoma, Hepatocellular 3Neoplasms 2Neoplasm Metastasis 2Melanoma 2Colorectal Neoplasms 2Stomach Neoplasms 1Sarcoma, Kaposi 1Recurrence 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Metastatic Squamous Non-Small Cell Lung Carcinoma 1Mesothelioma, Malignant 1Mesothelioma 1Kidney Neoplasms 1Head and Neck Neoplasms 1HIV Infections 1Endometrial Neoplasms 1Carcinoma, Neuroendocrine 1Carcinoma, Medullary 1Carcinoma 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

pembrolizumab 30Carboplatin 13Trastuzumab 8Paclitaxel 7Nivolumab 7Cisplatin 6Ipilimumab 5Cetuximab 5Bevacizumab 5Taxes 4Pemetrexed 4Specimen Handling 3Irinotecan 3Docetaxel 3Cyclophosphamide 3Biopsy 3tisotumab vedotin 2temsirolimus 2spartalizumab 2sargramostim 2pertuzumab 2lenvatinib 2fludarabine 2epacadostat 2enzalutamide 2aldesleukin 2X-Rays 2Ritonavir 2Psychiatric Rehabilitation 2Oxaliplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Neoplasms × cabozantinib × Thoracic × Clear all
NCT03170960 2025-08-17

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Exelixis

Phase 1 Active not recruiting
914 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡